Funding for this research was provided by:
Strategic Priority Research Program of the Chinese Academy of Sciences (XDA01030505)
Jiangsu Provincial Key Medical Center (yxzxb2016004)
Jiangsu Translational Medicine Program (BE2016612)
Jiangsu Biobank of Clinical Resources (BM2015004)
Excellent Youth Natural Science Foundation of Jiangsu Province (BK20170051)
Received: 6 December 2017
Revised: 14 March 2018
Accepted: 14 May 2018
First Online: 11 July 2018
Ethics approval and consent to participate
: This study was approved by the Ethics Committee on Human Research of the Nanjing Drum Tower Hospital (No. 201406401). Patients were assessed for eligibility between November 2014 and February 2015 (NCT 02313415). Informed consent for the cell therapy performed in the current study was obtained from every patient. The human newborn umbilical cord tissues used in this study were obtained from the 306th Hospital (Beijing, China) and cultured by the Institute of Zoology, Chinese Academy of Sciences (Beijing, China). No tissues were obtained from prisoners.
: Consent for publication was also obtained from every patient.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.